DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020
|
By LabMedica International staff writers Posted on 06 Feb 2020 |
|
Illustration
DAS Srl (Lazio, Italy) displayed the AP22 IF BLOT ELITE system and its lineup of standalone instruments at MEDLAB Middle East, one of the world’s major events in the field of medical diagnostics that was held in Dubai World Trade Center and attended by thousands of visitors from over 135 countries.
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.
DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.
DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).
Related Links:
DAS Srl
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Aliquoting Pipet Controller
ALI-Q 2 Series
Latest MEDLAB 2020 News
- Diagnostica Stago Displays STA Compact Max and STA Satellite Max Analyzers at MEDLAB
- GeneMatrix Promotes Sex and Respiratory Infection Testing Products at MEDLAB
- Mindray Showcases Comprehensive IVD Solutions Portfolio at MEDLAB Middle East 2020
- New Technology that Detects MRSA in 15 Minutes Introduced at MEDLAB Middle East 2020
- Vircell Exhibits Its New VirClia Lotus and qSPEED-OLIGO Systems at MEDLAB
- Randox Showcases New All-In-One Solution for Molecular Diagnostics at MEDLAB Middle East 2020
- EKF Diagnostics Displays POC Analyzers for Hemoglobin, HbA1c And Lactate at MEDLAB Middle East
- Erba Mannheim Launches New Electrolyte Analyzer with Maintenance-free Electrodes at MEDLAB 2020
- MEDLAB Middle East 2020 Addresses Future of Laboratory Medicine
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Distinguishes Deadly Cardiac Events
Two life-threatening cardiovascular emergencies—myocardial infarction and aortic dissection—often present with the same symptom: sudden, severe chest pain. Yet the treatments for these conditions are fundamentally... Read more
Blood Test Tracks Transplant Health Using Donor DNA
Organ transplantation offers life-saving treatment for patients with end-stage disease, but complications such as rejection remain a constant risk. Monitoring transplanted organs typically relies on invasive... Read more
Molecular Diagnostics
view channel
Alzheimer's Blood Marker Could Improve Detection of Heart and Kidney Diseases
A blood protein widely used as an early indicator of Alzheimer’s disease may not be as specific as once thought. Researchers have now found that phosphorylated tau (pTau), a key biomarker linked to ne... Read more
Single Blood Test Predicts Heart Diseases 15 Years Before Onset
Cardiovascular diseases remain the leading cause of death worldwide, claiming nearly 19.8 million lives in 2022 alone. Early identification of individuals at risk is critical for prevention, yet conventional... Read more
New Blood Test Aims to Transform Liver Cancer Surveillance
Liver cancer is one of the fastest‑growing causes of cancer‑related death in the U.S., and surveillance programs face gaps in performance and patient adherence that contribute to late diagnoses.... Read more
Blood Immune 'Fingerprint' Predicts Side Effects of New Alzheimer's Drug
New antibody therapies for Alzheimer’s disease have shown promise in slowing disease progression, but their broader use has been limited by a common side effect known as amyloid-related imaging abnormalities (ARIA).... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Immunology
view channel
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read moreMicrobiology
view channel
Study Highlights Accuracy Gaps in Consumer Gut Microbiome Kits
Direct-to-consumer gut microbiome kits promise personalized insights by profiling fecal bacteria and generating health readouts, but their analytical accuracy remains uncertain. A new study shows that... Read more
WHO Recommends Near POC Tests, Tongue Swabs and Sputum Pooling for TB Diagnosis
Tuberculosis (TB) remains one of the world’s leading infectious disease killers, yet millions of cases go undiagnosed or are detected too late. Barriers such as reliance on sputum samples, limited laboratory... Read more
Pathology
view channel
New Chromogenic Culture Media Enable Rapid Detection of Candida Infections
Invasive Candida infections are challenging for healthcare systems, with some strains spreading rapidly in hospitals and showing resistance to multiple antifungal drugs. Candida auris is associated with... Read more
Novel mcPCR Technology to Transform Testing of Clinical Samples
DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more
Technology
view channel
New Electronic Pipette Enhances Workflows with Touchscreen Control
Manual pipetting remains a routine yet error-prone step that can affect reproducibility and throughput in clinical and research laboratories. Training demands and ergonomic strain also add variability... Read more
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read more
Industry
view channel
New Partnership Brings Alzheimer’s Blood Biomarker Test to Community Screening Network
Lucent Diagnostics, a brand of Quanterix Corporation, has partnered with Life Line Screening (LLS) to offer Lucent’s non‑invasive, blood‑based biomarker test across the United States. Programs are... Read more
MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition
MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Agilent Technologies Acquires Pathology Diagnostics Company Biocare Medical
Agilent Technologies (Santa Clara, CA, USA) has entered into a definitive agreement to acquire Biocare Medical (Pacheco, CA, USA), expanding its pathology portfolio through the addition of highly complementary... Read more
